These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 39025435

  • 1. Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.
    Keenan TDL, Agrón E, Keane PA, Domalpally A, Chew EY, Age-Related Eye Disease Study Research Group, Age-Related Eye Disease Study 2 Research Group.
    Ophthalmology; 2025 Jan; 132(1):14-29. PubMed ID: 39025435
    [Abstract] [Full Text] [Related]

  • 2. Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: Age-Related Eye Diseases Study 2 Report 34.
    Duic C, Vance E, Agrón E, Keenan TDL, AREDS2 Research GroupDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland..
    Ophthalmol Retina; 2024 Nov 14. PubMed ID: 39547357
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR, Lawrenson JG.
    Cochrane Database Syst Rev; 2023 Sep 13; 9(9):CD000254. PubMed ID: 37702300
    [Abstract] [Full Text] [Related]

  • 5. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group.
    JAMA; 2013 May 15; 309(19):2005-15. PubMed ID: 23644932
    [Abstract] [Full Text] [Related]

  • 6. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F, Chiu CY, Agrón E, Clemons TE, Ratnapriya R, Swaroop A, Klein ML, Fan R, Chew EY, Age-Related Eye Disease Study 2 Research Group.
    Ophthalmology; 2019 Nov 15; 126(11):1541-1548. PubMed ID: 31358387
    [Abstract] [Full Text] [Related]

  • 7. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH.
    Cochrane Database Syst Rev; 2015 Oct 26; 2015(10):CD007698. PubMed ID: 26497719
    [Abstract] [Full Text] [Related]

  • 8. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD.
    JAMA Ophthalmol; 2014 Feb 26; 132(2):142-9. PubMed ID: 24310343
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial.
    Nielsen JS, Chang A, Holekamp NM, Cavichini-Cordeiro M, Lin SL, Heinrich D, Maass KF, Menezes A, Singh N, Pieramici DJ.
    Ophthalmol Retina; 2024 Dec 26; 8(12):1127-1139. PubMed ID: 38914294
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interventions for treating lymphocytic colitis.
    Chande N, Al Yatama N, Bhanji T, Nguyen TM, McDonald JW, MacDonald JK.
    Cochrane Database Syst Rev; 2017 Jul 13; 7(7):CD006096. PubMed ID: 28702956
    [Abstract] [Full Text] [Related]

  • 18. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C, Ni H, Aung HH.
    Cochrane Database Syst Rev; 2024 Aug 12; 8(8):CD014869. PubMed ID: 39132750
    [Abstract] [Full Text] [Related]

  • 19. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY, Schneider L, Loy C.
    Cochrane Database Syst Rev; 2024 Nov 05; 11(11):CD001747. PubMed ID: 39498781
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.